CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- 4 Shares withheld for taxes VP of Engineering gave up 65 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 63 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 87 shares (to pay taxes)
- 4 Open-market sale 10% owner sold 260,963 shares at an average $2.48 ($646,608)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 3,153,138 shares at an average $4.61 ($14,546,264)
- 4 Shares withheld for taxes Chief Financial Officer gave up 180 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 160 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 154 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 877 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 878 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 180 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 155 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 155 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Chairman gave up 889 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 177 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Engineering gave up 158 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Research & Development gave up 191 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
Page 6 of 21 · 406 filings